Skip to content

menu

Pharma in Brief logo
HomeAboutContact
Search
Close
Pharmaceuticals and life sciencesIntellectual propertyLife sciences and healthcare
View topics Archives
Subscribe

Pharma in Brief

Intellectual Property

Subscribe to Intellectual Property via RSS

Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases

Photo of Pharma in Brief team
By Pharma in Brief team on April 10, 2017

Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of…

Pharma in brief – TMOB dismisses section 45 proceedings for the trade-mark REMODULIN

Photo of Kristin Wall
By Kristin Wall on March 21, 2017

Case: Blake, Cassels & Graydon LLP v United Therapeutics Corporation, 2017 TMOB 9

Trade-Mark: REMODULIN

Nature of case: Summary expungement proceedingpursuant to section 45 of Trade-marks Act

Successful party: United Therapeutics Corporation

Date of decision: January 26, 2017

Summary

…

Subscribe to Pharma in Brief

Subscribe to this publication

Pharma in Brief

LinkedIn Twitter Facebook RSS YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date with legal and regulatory developments affecting the pharmaceutical industry. Pharma in Brief provides timely updates with a focus on the key take-away you need to know.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.